Spine360: The IP Agreements Behind the Kickback Allegations

In the Spine360 settlement, Omni Surgical L.P., doing business as Spine 360, and an Indiana spinal surgeon agreed to pay $2.6 million to the United States to resolve allegations of kickbacks disguised as intellectual-property payments. The government alleged that the manufacturer paid an entity the surgeon controlled to buy his use of its implants. The agreements called it intellectual property. The alleged purchase was the surgeon’s business.

Spine 360 manufactured devices used in spinal surgery and was based in Austin, Texas. The Department of Justice announced the settlement on August 29, 2014. The amount covered the company and the surgeon together.

How the Alleged Sham IP Agreements Worked

The government alleged that Spine 360 made the payments between 2007 and 2009 under a series of sham intellectual-property agreements. The money went to an entity controlled by the surgeon to compensate him for using Spine 360 products in his surgeries, according to the Justice Department.

That allegation puts the purpose of the payment at the center of the case. On paper, the manufacturer was paying under IP agreements. The United States alleged that what it was buying was product use. The surgeon’s controlled entity sat on the receiving end of the payments, while the surgeon made the clinical choice that could produce sales for the manufacturer.

Why the Surgeon’s Product Choice Matters

A surgeon can strongly influence which implant a hospital buys even though the hospital pays for it. The Department of Health and Human Services’ Office of Inspector General explains in its Special Fraud Alert on Physician-Owned Entities that implantable devices are physician preference items: physicians may choose or strongly influence both the brand and the type of device used in a procedure.

This gives a manufacturer a commercial reason to cultivate the surgeon. Winning that preference can mean winning the hospital’s purchase. In a kickback allegation, the question is whether payments bought that preference and the resulting business.

In announcing the Spine360 settlement, the Justice Department explained why improper financial incentives matter: medical judgment should follow the patient’s needs, and improper financial relationships can distort that judgment and increase health care costs.

How Does Reimbursement Work for Medical Devices?

For most implanted devices, Medicare pays the hospital through the payment for the procedure or stay, with the implant cost included. The commercial chain therefore runs through different hands: the surgeon influences the selection, the hospital buys the device, and the hospital submits the surgery claim.

A manufacturer payment can sit in the device company’s accounts while the government claim sits in the hospital’s billing system. Connecting the payment to product selection and then to the surgery explains why an arrangement inside a manufacturer can matter to a bill submitted elsewhere.

What an IP Agreement Could Hide

An IP arrangement describes an asset the manufacturer says it is paying to acquire or use. Understanding an alleged sham means comparing that description with the work, the product and the business the manufacturer expected from the surgeon.

The useful questions are concrete. What did the surgeon contribute? What did the manufacturer value and develop? Did the compensation depend on the surgeon’s own device use? What did the people approving the payment say they expected in return? These are the questions we examine with an insider who knows the arrangement.

Across device royalty and acquisition-fee cases, the issues include payments on a surgeon’s own cases, rates that move with product use, and payments for purported IP that never enters meaningful product development. Those circumstances connect the contract to what happened inside the business. An engineering employee may understand the claimed invention. A sales employee may understand the implant business attached to the payment. Finance may see how the compensation was calculated.

The Entity Receiving the Money

In the Spine360 case, the government alleged that the recipient was a surgeon-controlled entity. That detail matters because the name on a payment can be a business while the person whose product choice matters is a physician.

The inspector general’s broader alert on physician-owned entities also reaches businesses that purport to design or manufacture their own devices under contractual arrangements. The alert connects the physician’s financial interest in the selling business with the physician’s influence over hospital purchases.

Arthrex and the Expectation of Product Loyalty

In the separate Arthrex case, the government alleged that royalty payments induced a surgeon’s use and recommendation of its products, causing false Medicare claims.

What Evidence Is Needed to Prove Fraud?

For an alleged IP payment scheme, the useful evidence connects the agreement, the payment recipient, the manufacturer’s purpose, the surgeon’s device use and the resulting government claim. We work with the insider to establish those connections across the business and the hospital.

The 2020 review A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, published in the Journal of Forensic and Investigative Accounting, describes kickbacks paid indirectly or through benefits other than cash, as well as economic relationships more complex than a simple payment for services. Applied to a surgeon-controlled entity, that means understanding the relationship behind the payee’s name and following the alleged exchange into product use.

Someone who worked on the product may be able to explain what the claimed contribution actually changed. Someone responsible for the surgeon’s account may know how payments and product use were discussed together. We bring those accounts into the same case, with medical device fraud whistleblower lawyers who understand physician-payment arrangements.

How Much Does a Medicare Fraud Whistleblower Get Paid?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know What the Payment Was For

If your work in healthcare involves IP agreements, surgeon accounts or implant purchases, speak to one of our Whistleblower Experts about what the manufacturer expected in return. We work with you to build your strongest medical device whistleblower case around the business you know, bring in medical device fraud whistleblower lawyers who understand royalty and IP payments, and remain your partners throughout the case.